KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. With each of our 500+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. KBI is proud to be a JSR Life Sciences Company.
View Top Employees from KBI BiopharmaWebsite | http://www.kbibiopharma.com |
Revenue | $268.4 million |
Funding | $9.6 million |
Employees | 1,709 (1,709 on RocketReach) |
Founded | 1996 |
Address | 4117 Emperor Blvd, Durham, North Carolina 27703, US |
Phone | (919) 479-9898 |
Technologies |
JavaScript,
HTML,
Twitter
+51 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biopharma, Cell Line Development, Healthcare, Biotechnology, Process & Analytical Development, Health Care, Clinical Manufacturing, Science and Engineering, Commercial Manufacturing, Manufacturing, Characterization & Consulting |
Web Rank | 1 Million |
Keywords | Biomanufacturing, Biotechnology, Pharmaceutical Drug Development |
Competitors | Aldevron, Cambrex, Celltrion Pharm Inc., Dpt Labs, FUJIFILM Diosynth Biotechnologies |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular KBI Biopharma employee's phone or email?
The KBI Biopharma annual revenue was $268.4 million in 2024.
Tony Fraij is the COO of KBI Biopharma.
1,709 people are employed at KBI Biopharma.
KBI Biopharma is based in Durham, North Carolina.
The NAICS codes for KBI Biopharma are [54171, 54, 541711, 541, 5417].
The SIC codes for KBI Biopharma are [28, 283].